How do clinical pharmacists keep up-to-date with newly approved medications? Update on newly approved medications from the Food and Drug Administration (FDA) in the United States

How do clinical pharmacists keep up-to-date with newly approved medications? Update on newly approved medications from the Food and Drug Administration (FDA) in the United States

7^th World Congress on Clinical Pharmacy and Pharmacy Practice
December 07-09, 2017 | Rome, Italy

Golden L Peters

Saint. Louis College of Pharmacy, USA

Scientific Tracks Abstracts : J Pharmacol Ther Res

Abstract:

In 2016, 22 new medications were approved by the Food and Drug Administration (FDA) in the United States and there have been 31 new medications approved in 2017, thus far. The presentation will highlight each medications indication, specific mechanism of action, dosing information, contraindications, precautions, adverse drug reactions, drug interactions, special administration techniques (when needed), and potential place in current therapy. The presentation will also highlight any special patient instruction or monitoring parameters for providers to consider when prescribing these new medications. (e.g. injection techniques, priming requirements). The focus of this presentation will be to introduce new molecular entities to all attendees from around to world to help shed light on the ever growing and rapidly changing healthcare field. Reinforcing that we are all a part of the global community, despite our physical geographic location.

Biography:

Golden L Peters has received his BA degree from Fontbonne University in Clayton, Missouri, USA and his Doctor of Pharmacy degree from Southern Illinois University Edwardsville in 2009. He has completed a PGY-1 Pharmacy Practice Residency in 2010 at St. Elizabeth’s Hospital in affiliation with Southern Illinois University Edwardsville School of Pharmacy. He is currently an Associate Professor of Pharmacy Practice at the St. Louis College of Pharmacy. He is also a Clinical Pharmacy Specialist in Primary Care at the VA St. Louis Health Care System, John Cochran Division. He is an Editorial Board Member for Madridge Journal of Pharmaceutical Research. He has over 25 publications and more than 20 invited international presentations, spanning North America, Europe, Africa, and Asia

PDF HTML